PCSA - Processa Pharmaceuticals - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

-2.348M

Cash

8.677M

Avg Qtr Burn

-2.413M

Short % of Float

0.69%

Insider Ownership

16.23%

Institutional Own.

6.53%

Qtr Updated

06/30/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
PCS12852 Details Opioid induced constipation, Post-op GI Dysfunction	Phase 2a Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
NGC-Cap (PCS6422 w/ capecitabine) Details Solid tumor/s, Colorectal cancer , Cancer, Metastatic breast cancer	Phase 1b Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
PCS499 Details Ulcerative Necrobiosis Lipoidica	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.